Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

MDxHealth (MDXH) Shares Outstanding (2021 - 2025)

MDxHealth has reported Shares Outstanding over the past 4 years, most recently at $51.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 3.77% year-over-year to $51.4 million; the TTM value through Dec 2025 reached $51.4 million, up 3.77%, while the annual FY2025 figure was $51.4 million, 3.77% up from the prior year.
  • Shares Outstanding was $51.4 million for Q4 2025 at MDxHealth, up from $49.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $156.0 million in Q4 2021 and bottomed at $27.3 million in Q4 2023.
  • The 4-year median for Shares Outstanding is $50.4 million (2024), against an average of $71.0 million.
  • Year-over-year, Shares Outstanding skyrocketed 81.39% in 2024 and then grew 3.77% in 2025.
  • Over 4 years, Shares Outstanding stood at $156.0 million in 2021, then tumbled by 82.5% to $27.3 million in 2023, then skyrocketed by 81.39% to $49.5 million in 2024, then rose by 3.77% to $51.4 million in 2025.
  • The last three reported values for Shares Outstanding were $51.4 million (Q4 2025), $49.5 million (Q4 2024), and $27.3 million (Q4 2023) per Business Quant data.